CELL THERAPY PRODUCT FOR BONE REGENERATION AND PREPARATION METHOD THEREFOR

The present invention relates to a cell therapy product for treatment of a bone disease, which is prepared by mixing bone cells differentiated from umbilical cord-derived mesenchymal stem cells with undifferentiated, umbilical cord-derived mesenchymal stem cells at a certain ratio. More particularly...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PARK, Jang Mi, CHU, Seol, LEE, Jong Min, MO, Hyun Jung, PARK, Hyun Sook, LEE, Sun Ray
Format: Patent
Sprache:eng ; fre ; kor
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to a cell therapy product for treatment of a bone disease, which is prepared by mixing bone cells differentiated from umbilical cord-derived mesenchymal stem cells with undifferentiated, umbilical cord-derived mesenchymal stem cells at a certain ratio. More particularly, the present invention can provide a cell therapy product capable of effectively treating bone diseases, wherein differentiated bone cells are mixed at a ratio of 0.5 to 1.5 with undifferentiated cells, whereby the undifferentiated cells promote angiogenesis and thus bone reconstruction or osteogenesis. La présente invention concerne un produit de thérapie cellulaire, pour le traitement de maladies osseuses, qui est préparé par mélange de cellules osseuses différenciées provenant de cellules souches mésenchymateuses dérivées de cordon ombilical avec des cellules souches mésenchymateuses indifférenciées, dérivées de cordon ombilical, selon un rapport donné. Plus particulièrement, la présente invention peut fournir un produit de thérapie cellulaire capable de traiter efficacement des maladies osseuses, les cellules osseuses différenciées étant mélangées avec les cellules indifférenciées selon un rapport compris entre 0,5 et 1,5, les cellules indifférenciées favorisant l'angiogenèse et, de ce fait, la reconstruction osseuse ou l'ostéogenèse. 본 발명은 탯줄유래 간엽줄기세포에서 유래된 골세포로 분화된 세포 및 미분화된 탯줄유래 간엽줄기세포를 특정 비율로 혼합하여 제조된 골 질환 치료용 세포 치료제에 관한 것이다. 보다 상세하게는 본 발명은 미분화 세포에 대하여 골세포로 분화된 세포를 0.5 내지 1.5 비율로 혼합하여 사용함으로써, 미분화 세포가 혈관형성을 촉진함으로써 골재건 또는 골 형성을 촉진시킴으로써 골 질환을 효과적으로 치료할 수 있는 세포치료제를 제공할 수 있다.